-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 6, Lingkang Pharmaceutical issued an announcement stating that the company’s wholly-owned subsidiary, Meilan Shik Pharmaceutical, recently received the "Drug Registration Approval Document" for Piperacillin Sodium and Sulbactam Sodium for Injection approved and issued by the State Food and Drug Administration.
Piperacillin sodium and sulbactam sodium for injection (4:1) Indications: suitable for moderate to severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin and sensitive to this product.